I haven't watched the webcast yet, but will hopefully skip through to see some discussions over the next week.
Training will be paramount on new RASDs that are released to the market. IMO, the entire industry needs a reformat to introduce centers of excellence to maximize technique and patient outcomes using these devices.
I know of surgeons and surgical centers that are "world-renowned" and do some of the highest volume of procedures in the world and their outcomes are inferior to other surgeons and centers that do much lower volumes. You wouldn't know this unless you have seen the data behind the surgeries (which is not published). They are using the same Da Vinci robot as other physicians, so one can only assume that their training or technique is producing poor results in comparison to the rest of the industry. Scary.
Titan will need to take a very calculated approach to selecting doctors for their trials, initial roll out and proctorship/training programs. Not only is the industry not controlled properly IMO, but it will be an entirely new device. I think Titan knows this and is acting accordingly based off previous new of training partnerships and what not.
News 
Market Data 
Discover 
